Amlodipine and Benazepril |
Lotrel |
This article or section does not cite its references or sources. You can help Wikipedia by introducing appropriate citations. Lotrel contains two prescription medicines that work together to lower blood pressure: amlodipine besylate (the active ingredient found in Norvasc®), a calcium channel blocker, and benazepril hydrochloride (Lotensin®), an ACE inhibitor. A doctor will prescribe Lotrel only after other medicines haven't worked. This medical treatment article is a stub. You c ...
Wikipedia - [full article]
Amlodipine and Benazepril Clinical Trials
- Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients with Type 2 Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00136773 - Active, not recruiting
Albuminuria
- A 6-Week Multi-Center, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension
ClinicalTrials.gov Identifier: NCT00136851 - Completed
Hypertension
- Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients with High Risk Hypertension
ClinicalTrials.gov Identifier: NCT00139555 - Active, not recruiting
Hypertension; Left Ventricular Hypertrophy
- A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.
ClinicalTrials.gov Identifier: NCT00171366 - Active, not recruiting
Hypertension
- Avoiding Cardiovascular Events through Combination therapy in patients with Systolic Hypertension ACCOMPLISH
ClinicalTrials.gov Identifier: NCT00097864 - No longer recruiting
Heart Disease
- A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
ClinicalTrials.gov Identifier: NCT00171119 - Active, not recruiting
Hypertension; Diabetic Nephropathy
- Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00367978 - Completed
Hypertension
- Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension
ClinicalTrials.gov Identifier: NCT00558428 - Recruiting
Hypertension
- Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00413049 - Active, not recruiting
Hypertension
- Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00413413 - Active, not recruiting
Hypertension
- Safety and Efficacy of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension
ClinicalTrials.gov Identifier: NCT00437645 - Active, not recruiting
Essential Hypertension
- Treatment of High Blood Pressure Using Olmesartan with Hydrochlorothiazide Compared to an ACE Inhibitor with a Calcium Channel Blocker
ClinicalTrials.gov Identifier: NCT00185120 - Completed
Hypertension
- Long Term Study For Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is Insufficient
ClinicalTrials.gov Identifier: NCT00443456 - Recruiting
Hypertension
- Influence of Amlodipine on the Mortality of Patients with End-Stage Renal Failure
ClinicalTrials.gov Identifier: NCT00124969 - Active, not recruiting
Kidney Failure, Chronic
- Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension
ClinicalTrials.gov Identifier: NCT00553267 - Recruiting
Hypertension
- Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00426478 - Active, not recruiting
Hypertension
- Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone
ClinicalTrials.gov Identifier: NCT00171002 - Completed
Hypertension
- An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure
ClinicalTrials.gov Identifier: NCT00402103 - Active, not recruiting
Hypertension
- Comparison of Valsartan with Amlodipine in Hypertensive Patients with Glucose Intolerance
ClinicalTrials.gov Identifier: NCT00129233 - Recruiting
Hypertension; Type 2 Diabetes Mellitus; Impaired Glucose Tolerance
- Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension
ClinicalTrials.gov Identifier: NCT00171054 - Active, not recruiting
Hypertension
- Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension
ClinicalTrials.gov Identifier: NCT00400777 - Active, not recruiting
Hypertension
- Amlodipine Plus Botulinum Toxin for Focal Dystonia
ClinicalTrials.gov Identifier: NCT00015457 - Recruiting
Focal Dystonia
- Efficacy and Safety of Valsartan and Amlodipine in Adults With Moderate, Inadequately Controlled Hypertension
ClinicalTrials.gov Identifier: NCT00523744 - Active, not recruiting
Hypertension
- Filtered Trial for Amlodipine Non-Responder
ClinicalTrials.gov Identifier: NCT00558064 - Recruiting
Hypertension
- Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension
ClinicalTrials.gov Identifier: NCT00289406 - Completed
Hypertension
- Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension
ClinicalTrials.gov Identifier: NCT00350168 - Completed
Hypertension
- Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension
ClinicalTrials.gov Identifier: NCT00353912 - Completed
Hypertension
- Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia
ClinicalTrials.gov Identifier: NCT00174330 - Completed
Hypertension; Hyperlipidemia
- Losartan and HCTZ and Amlopidine Vs Atenolol and Amlodipine
ClinicalTrials.gov Identifier: NCT00140959 - Active, not recruiting
Hypertension
- Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)
ClinicalTrials.gov Identifier: NCT00446524 - Active, not recruiting
Hypertension
- Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
ClinicalTrials.gov Identifier: NCT00425997 - Active, not recruiting
Hypertension
- Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
ClinicalTrials.gov Identifier: NCT00509470 - Recruiting
Essential Hypertension
- Ranolazine SR in Patients with Chronic Angina Who Remain Symptomatic Despite Maximal Treatment with Amlodipine
ClinicalTrials.gov Identifier: NCT00091429 - Active, not recruiting
Angina
- Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension
ClinicalTrials.gov Identifier: NCT00333489 - Completed
Hypertension
- A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin
ClinicalTrials.gov Identifier: NCT00530946 - Recruiting
Hypercholesterolemia; Hypertension
- Amlodipine Diabetic Hypertension Efficacy Response Trial
ClinicalTrials.gov Identifier: NCT00159692 - Completed
Hypertension
- Efficacy and Safety of Lacidipine and Amlodipine on Blood Pressure in Korean ISH Patients Aged 60 to 80 Years
ClinicalTrials.gov Identifier: NCT00460915 - Recruiting
Hypertension
- Amlodipine Vs NItrates Study in Patients with Chronic Stable Angina (ANISSA)
ClinicalTrials.gov Identifier: NCT00143195 - Completed
Myocardial Ischemia
- Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
ClinicalTrials.gov Identifier: NCT00351130 - Active, not recruiting
Hypertension
- Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy
ClinicalTrials.gov Identifier: NCT00446563 - Active, not recruiting
Hypertension; Hypertrophy, Left Ventricular
- Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension
ClinicalTrials.gov Identifier: NCT00281580 - Recruiting
Hypertension
- Pharmacokinetic Drug Interaction Study Following co-Administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00548067 - Recruiting
Hypertension
- Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities
ClinicalTrials.gov Identifier: NCT00242814 - Recruiting
Hypertension; Metabolic Syndrome X
- Amlodipine/Atorvastatin Combination To Reduce The Health Risk Of High Blood Pressure And High Cholesterol Levels
ClinicalTrials.gov Identifier: NCT00143234 - Completed
Hypertension; Hyperlipidemia
- Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension
ClinicalTrials.gov Identifier: NCT00527514 - Recruiting
Hypertension
- Double Blind Atorvastatin Amlodipine Study (DUAAL Study)
ClinicalTrials.gov Identifier: NCT00159718 - Completed
Angina
- Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension
ClinicalTrials.gov Identifier: NCT00425373 - Recruiting
Essential Hypertension
- Effects of Aliskiren and Amlodipine on Insulin Resistance and Coronary Endothelial Function in Patients With Hypertension and Metabolic Syndrome.
ClinicalTrials.gov Identifier: NCT00417170 - Recruiting
Hypertension; Metabolic Syndrome X
- High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00313547 - Recruiting
Hypertension
- Olmesartan as an Add-on to Amlodipine in Hypertension
ClinicalTrials.gov Identifier: NCT00220233 - Completed
Essential Hypertension
- OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
ClinicalTrials.gov Identifier: NCT00134160 - Active, not recruiting
Aged; Hypertension; Diabetes Mellitus Type 2; Cardiovascular Diseases
- The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction
ClinicalTrials.gov Identifier: NCT00523549 - Recruiting
Hypertension; Diastolic Dysfunction
- Amlodipine as Add-on to Olmesartan in Hypertension
ClinicalTrials.gov Identifier: NCT00220220 - Completed
Essential Hypertension
- A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00538486 - Not yet recruiting
Hypertension; Obesity
- Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
ClinicalTrials.gov Identifier: NCT00000542 - Active, not recruiting
Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus; Heart Diseases; Hypercholesterolemia; Hypertension; Myocardial Infarction; ...
- Efficacy and Safety of Aliskiren +/- Ramipril When Added to Amlodipine in Hypertensive Patients With Metabolic Syndrome
ClinicalTrials.gov Identifier: NCT00542269 - Not yet recruiting
Hypertension With Metabolic Syndrome
- Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension
ClinicalTrials.gov Identifier: NCT00367094 - Completed
Hypertension
- A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00392262 - Completed
Hypertension
- Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00409643 - Completed
Hypertension
- Effects of Amlodipine in the Management of Chronic Heart Failure
ClinicalTrials.gov Identifier: NCT00151619 - Suspended
Chronic Heart Failure
- A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy
ClinicalTrials.gov Identifier: NCT00327145 - Completed
Hypertension
- A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders Patients
ClinicalTrials.gov Identifier: NCT00219076 - Completed
Hypertension
- The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients
ClinicalTrials.gov Identifier: NCT00338338 - Completed
Essential; Uncomplicated Hypertension
- Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension
ClinicalTrials.gov Identifier: NCT00171535 - Completed
Hypertension
- Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
ClinicalTrials.gov Identifier: NCT00171561 - Completed
Hypertension
- Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.
ClinicalTrials.gov Identifier: NCT00409760 - Completed
Hypertension
- Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone
ClinicalTrials.gov Identifier: NCT00170963 - Completed
Hypertension
- Study of co-Administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension
ClinicalTrials.gov Identifier: NCT00185133 - Completed
Hypertension
- One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00409851 - Completed
Hypertension
- Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
ClinicalTrials.gov Identifier: NCT00174304 - Completed
Hypertension; Hyperlipidemia
- Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
ClinicalTrials.gov Identifier: NCT00330785 - Completed
Hypertension; Dyslipidemia
- 8-Week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension
ClinicalTrials.gov Identifier: NCT00327587 - Completed
Hypertension
- Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine
ClinicalTrials.gov Identifier: NCT00367939 - Completed
Hypertension
- A Clinical Study to Compare Long-Term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine
ClinicalTrials.gov Identifier: NCT00219154 - Completed
Hypertension
- A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00170976 - Completed
Hypertension
- Benazepril for Advanced Chronic Renal Insufficiency
ClinicalTrials.gov Identifier: NCT00270426 - Terminated
Chronic Kidney Failure
- A Clinical Study to Compare Long-Term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine
ClinicalTrials.gov Identifier: NCT00294710 - Completed
Hypertension
- Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population
ClinicalTrials.gov Identifier: NCT00150384 - Completed
Hypertension; Dyslipidemia
- A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg
ClinicalTrials.gov Identifier: NCT00219115 - Completed
Hypertension
- A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient
ClinicalTrials.gov Identifier: NCT00415623 - Completed
Hypertension
- Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome
ClinicalTrials.gov Identifier: NCT00241150 - Completed
Hypertension; Metabolic Syndrome
- A Pilot Study of Use of Calcium Channel Blocker to Decrease Inflammation and Pain in Hereditary Pancreatitis
ClinicalTrials.gov Identifier: NCT00156403 - Completed
Pancreatitis
- Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
ClinicalTrials.gov Identifier: NCT00304226 - Completed
Hypertension
- A Comparison of Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg With Amlodipine 10 mg + Hydrochlorothiazide 12.5 mg in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension. A Prospective, Randomised, Open-Label, Blinded
ClinicalTrials.gov Identifier: NCT00240474 - Completed
Hypertension
- Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers
ClinicalTrials.gov Identifier: NCT00039975 - Completed
HIV Infections; Cardiovascular Diseases; Hypertension
- Hydrochlorothiazide (+) Losartan Potassium Vs. Amlodipine Comparative Study
ClinicalTrials.gov Identifier: NCT00157963 - Completed
Essential Hypertension
- Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency
ClinicalTrials.gov Identifier: NCT00338091 - Terminated
Renal Insufficiency,Chronic; Disease Progression; Proteinuria; Dose-Response Relationship,Drug; ACE Inhibitor; Angiotensin II Type 1 Receptor Blockers
- Treatment of Mild Hypertension Study (TOMHS)
ClinicalTrials.gov Identifier: NCT00000522 - Completed
Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases
Resources
- Amlodipine and Benazepril (Drug Digest)
- Lotrel (Drug Digest)

Not Signed In -

